Genoa, Italy

Fabio Benfenati

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 8.5

ph-index = 1


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Fabio Benfenati

Introduction

Fabio Benfenati is a notable inventor based in Genoa, Italy. He has made significant contributions to the field of medical technology, particularly in the development of compounds and devices aimed at treating eye disorders and inhibiting electrical activity in excitable cells. With a total of 2 patents, his work showcases a blend of chemistry and innovative engineering.

Latest Patents

Benfenati's latest patents include "Photochromic compounds for use in the treatment of eye disorders." This invention features compounds with a specific formula that includes various elements such as O, N, and P, which are designed to address eye disorders effectively. Another significant patent is for "Organic devices for the photoinhibition of excitable cells." This device utilizes a photoreactive film that, when exposed to light, can inhibit the electrical activity of excitable cells, showcasing a novel approach to medical treatment.

Career Highlights

Throughout his career, Benfenati has worked with esteemed organizations such as the Fondazione Istituto Italiano Di Tecnologia and Politecnico Di Milano. His experience in these institutions has allowed him to advance his research and contribute to groundbreaking innovations in his field.

Collaborations

Benfenati has collaborated with notable colleagues, including Guglielmo Lanzani and Giuseppe Maria Paterno′. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Fabio Benfenati's contributions to the field of medical technology through his innovative patents highlight his role as a leading inventor. His work continues to influence advancements in the treatment of eye disorders and the inhibition of excitable cells.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…